Order Article Reprints

Koumarianou A, Pectasides D, Koliou G-A, Dionysopoulos D, Kolomodi D, Poulios C, Skondra M, Sgouros J, Pentheroudakis G, Kaltsas G, et al. Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study. Biology. 2020; 9(3):51. https://doi.org/10.3390/biology9030051

Koumarianou, Anna, Dimitrios Pectasides, Georgia-Angeliki Koliou, Dimitrios Dionysopoulos, Dionysia Kolomodi, Christos Poulios, Maria Skondra, Joseph Sgouros, George Pentheroudakis, Gregory Kaltsas, and et al. 2020. "Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study" Biology 9, no. 3: 51. https://doi.org/10.3390/biology9030051

Koumarianou, A., Pectasides, D., Koliou, G.-A., Dionysopoulos, D., Kolomodi, D., Poulios, C., Skondra, M., Sgouros, J., Pentheroudakis, G., Kaltsas, G., & Fountzilas, G. (2020). Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study. Biology, 9(3), 51. https://doi.org/10.3390/biology9030051